Your search returned 20 studies. (Get alerts for new studies):
- T-cell Recovery in Patients With Leukemia, Advanced Lymphoma, Myelodysplastic Syndrome, or Myeloproliferative Disorder Receiving Alemtuzumab and Under
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies
Conditions: Leukemia - Lymphoma - Myeloma
1 Location available
- AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
1 Location available
- Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias
Conditions: Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - High-risk Myelodysplastic Syndrome - Chronic Lymphocytic Leukemia - Advanced Myelofibrosis
1 Location available
- Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer o
Conditions: Graft Versus Host Disease - Leukemia - Myelodysplastic Syndromes
1 Location available
- A Trial In Patients With Advanced Cancer And Leukemia
Conditions: Neoplasms by Histologic Type - Leukemia, Lymphoid - Leukemia, T-Cell - Solid Tumors
6 Locations available
- Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndrome - Chronic Lymphocytic Leukemia - Mantle Cell Lymphoma
1 Location available
- PXD101 and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies
Conditions: Leukemia - Myelodysplastic Syndrome
1 Location available
- Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies
Conditions: Acute Myeloid Leukemia - Lymphoblastic Leukemia - Acute Leukemia - Non Hodgkins Lymphoma - Chronic Myeloid Leukemia
1 Location available
- 4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies
Conditions: Leukemia
1 Location available
- AHN-12 Biodistribution in Advanced Leukemia
Conditions: Acute Myelogenous Leukemia - Myelodysplastic Syndrome - Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia
1 Location available
- Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Ac
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) - Adult Acute Myeloid Leukemia With t(16;16)
1 Location available
- Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Ad
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) - Adult Acute Myeloid Leukemia With t(16;16)
3 Locations available
- Study of the T-cells or EBV Specific CTLs for Advanced B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Non-Hodgkin Lymphoma - Chronic Lymphocytic Leukemia
2 Locations available
- Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia
Conditions: Leukemia - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Phase II Study of Ofatumumab in Elderly Patients With Chronic Lymphocytic Leukemia (CLL)
Conditions: Advanced Cancers - Leukemia
1 Location available
- Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matche
Conditions: Acute Myeloid Leukemia - Advanced Myelodysplastic Syndromes
1 Location available
- ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies
Conditions: Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - B-cell Chronic Lymphocytic Leukemia - Myelodysplasia
2 Locations available
- Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or
Conditions: Acute Myeloid Leukemia - Advanced Myelodysplastic Syndrome
1 Location available
|